Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: Results from two randomized placebo-controlled clinical trials

OBJECTIVE: To assess the safety and efficacy of ABT-089, a novel α(4)β(2) neuronal nicotinic receptor partial agonist, vs. placebo in children with attention-deficit/hyperactivity disorder (ADHD). METHOD: Two multicenter, randomized, double-blind, placebo-controlled, parallel-group studies of childr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wilens, Timothy E., Gault, Laura M., Childress, Ann, Kratochvil, Christopher J., Bensman, Lindsey, Hall, Coleen M., Olson, Evelyn, Robieson, Weining Z., Garimella, Tushar S., Abi-Saab, Walid M., Apostol, George, Saltarelli, Mario D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3757954/
https://ncbi.nlm.nih.gov/pubmed/21156272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaac.2010.10.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi